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Abstract In mammals, leukotriene A4 hydrolase converts 
leukotriene A4 into the proinflammatory mediator leukotriene 
B4. We have purified and characterized a non-mammalian 
leukotriene A4 hydrolase from Xenopus laevis oocytes. This 
enzyme contains one zinc atom and catalyzes an anion-dependent 
peptidase activity, two key features of the mammalian enzymes. 
The amino acid sequence of an internal segment is 60% identical 
with human leukotriene A4 hydrolase but only 27% identical with 
rat aminopeptidase B. The Xenopus laevis enzyme is catalytically 
very efficient and, unlike the human enzyme, converts ieukotriene 
A4 into two enzymatic metabolites, viz. leukotriene B4 and A 6- 
trans-AS-cis-leukotriene B 4. 
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1. Introduction 
Leukotriene (LT) A,I hydrolase catalyzes the final step in 
the biosynthesis of LTB4, a potent chemotaxin and leukocyte 
activating agent [1]. The mammal ian LTA4 hydrolase is a 
soluble monomeric metal loenzyme with a molecular mass of 
about 69 kDa containing one catalytic zinc [24].  In addit ion 
to the epoxide hydrolase activity, i.e. the hydrolysis of LTA4 
into LTB4, the enzyme also possesses an anion-dependent 
peptidase activity, the physiological role of which is still un- 
known [4-7]. The primary structure of LTA4 hydrolase is 33% 
identical to that of aminopeptidase B, which has also been 
reported to possess LTA4 hydrolase activity [8]. 
In a recent study we found that organ extracts of the Afri- 
can claw toad Xenopus laevis converted LTA4, not only into 
LTB4, but also into a novel biologically active metabolite, 
structurally identified as 5S,12R-dihydroxy-6,10-trans-8,14- 
cis-eicosatetraenoic acid (A6-trans-AS-cis-LTB4) [9]. We also 
discovered that the reproduction organs, i.e. oocytes and 
testes, are very rich in LTA4 hydrolase activity, a circum- 
stance which has now enabled us to purify and characterize 
the enzyme from a non-mammal ian source. In the present 
report we show that the Xenopus laevis protein is a bifunc- 
tional zinc metalloenzyme which is structurally distinct from 
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aminopeptidase B and exhibits high catalytic efficiencies as 
well as the ability to convert LTA4 into A6-trans-A%cis-LTB4. 
2. Materials and methods 
2.1. Preparation of oocytes 
Female Xenopus laevis toads, 60-90 g (Blades Biological, UK), were 
decapitated and the oocytes were removed and kept on ice prior to 
homogenization in one part (mass/vol.) 50 mM Tris-HC1 buffer, pH 8, 
and 2 mM EDTA, utilizing a Potter-Elvehjem homogenizer. The 
10 000 x g supernatants of the homogenates are referred to as cytosol. 
2.2. Protein purification 
Nucleic acids were removed from cytosol by streptomycin sulfate 
precipitation followed by centrifugation (10000×g; 15 rain; 4°C). 
The supernatant was subjected to ammonium sulfate precipitation 
on ice. After removal of the 0-35°/,, precipitate, the solution was sat- 
urated to 80°/,,. Proteins were pelleted by eentrifugation a d dissolved 
in 10 mM Tris-HCl, pH 8. 
For anion-exchange chromatography on FPLC (Pharmacia), a col- 
umn packed with Q Sepharose Fast Flow (Pharmacia) was equili- 
brated with 10 mM Tris-HC1, pH 8. The 35 80% ammonium sulfate 
fraction was dialyzed against he equilibration buffer, treated with 
dithiothreitol (2 mM, 30 min), and applied to the column. Adsorbed 
proteins were eluted with a gradient of KCI (0-500 mM) and the 
enzyme activity was recovered between 140 and 190 raM. Active frac- 
tions were supplemented with 20°/`} (mass/vol.) ammonium sulfate and 
applied to a phenyl Superose, HR 5/5 (Pharmacia) column pteequili- 
brated in 20 mM Tris-HC1 buffer, pH 8, containing 150 mM ammo- 
nium sulfate. A linear gradient of ammonium sulfate (150-0 mM) was 
applied and the enzyme activity was eluted between 67 and 45 mM. 
For hydroxyapatite chromatography, a TSKgel HA-1000 column (To- 
sohaas) was equilibrated in 10 mM potassium phosphate buffer, pH 
7.1, supplemented with 0.2 mM CaCI2. Pooled fractions from the 
hydrophobic interaction chromatography were applied in the equili- 
bration buffer. The column was eluted with a gradient of potassium 
phosphate (10-400 mM) and active fractions were eluted between 150 
and 190 mM. The final purification was achieved by chromatofocus- 
ing on a MonoP column HR 5/20 (Pharmacia) preequilibrated with 
25 mM Bis-Tris, pH adjusted to 7.l with iminodiacetic acid. Active 
fractions from the hydroxyapatite column, in 10 mM Tris-HCl, pH 
8.0, were applied to the column which was then eluted with a pH 
gradient (7.1-4.5). LTA4 hydrolase luted at a pH=pl  of about 6.1. 
For buffer exchange, a final chromatographic step was performed on 
a MonoQ HR 5/5 column (Pharmacia). LTA4 hydrolase was also 
purified from isolated human leukocytes, essentially as described [10]. 
2.3. Determinations of enzyme activities and protein concentrations 
The epoxide hydrolase activity was determined as described [9]. 
Briefly, aliquots of the enzyme pools (1% by vol.) in 100 lal, 10 mM 
Tris-HC1, pH 8, were incubated with 25 taM LTA4 for 10 s at room 
temperature. Formation of LTB4 was analyzed by reverse-phase 
HPLC at 270 nm, using prostaglandin B1 as the internal standard. 
The column (Nova-Pak C~8, 4 tam Radial-Pak cartridge, 5× 100 mm, 
Waters) was eluted with a mixture of acetonitrile/methanol/waterlacet- 
ic acid (30:35:35:0.01, v/v) at 1.0 ml/min. 
The peptidase activity was determined, essentially as described [10]. 
Alanine-4-nitroanilide was dissolved to a concentration of 1 mM in 
50mM Tris-HCl, pH 7.5, containing 100 mM KC1 or, in some experi- 
ments, KSCN, NaBr, NaCI, NaF, NaI, NaNO:~ or NaSCN between 
0014-5793/98/$19.00 © 1998 Federation of European Biochemical Societies. All rights reserved. 
PII: S00 1 4 -5793{98)009 1 8- 1 
220 
12.5 and 800 mM. The product (4-nitroaniline) was measured spec- 
trophotometrically at 405 nm. 
Protein concentrations were determined according to Bradford [11], 
using the Bio-Rad protein assay reagent and bovine serum albumin as 
standard. 
2.4. SDS-PAGE, Western blot. and isoelectricJocusing 
Aliquots of purified protein (2 4 p.g) were subjected to SDS-PAGE 
(stacking gel 5%; separating gel 10%) on a Mini-Protean II (Bio-Rad) 
apparatus [12] or on a PhastSystem (Pharmacia) using PhastGels, 
gradient 10 15%. The gels were stained with Coomassie brilliant 
blue or AgNO:~. Western blot analysis was carried out with an affin- 
ity-purified polyclonal antiserum against human LTA4 hydrolase, as 
described [9]. For isoelectric focusing, PhastGels IEF 3-9 were used 
and stained with Coomassie brilliant blue. 
2.5. Am&o acid sequence analysis 
LTA.~ hydrolase (40 ~g: 570 pmol) in 10 mM Tris-HCl, pH 8, was 
digested with Lys-C protease (4 ~tg, at 37°C, 18 h). Peptides were 
separated by HPLC on a Vydac Cs column (2.1X 150 mm), eluted 
with a gradient of acetonitrile (5 80%) in 0.1% trifluoroacetic acid. 
Peptides were sequenced on an Applied Biosystems instrument model 
477A or 494. 
2.6. Metal analrses 
Zinc was measured by graphite furnace atomic absorption spectro- 
photometry using a Perkin-Elmer 5000 Zeeman instrument with an 
electrothermal tomization unit (HGA-500). Zinc was analyzed at 
213.9 nm using an EDL lamp. Mixed zinc standards (British Drug 
House, UK) were prepared in 0.03 M HNOs (10 200 ng/ml) and 
diluted 1:1 in the sample cups with deionized water (Elgastat Spec- 
trum R.O.I, ELGA, UK) prior to analysis. Samples of LTA=~ hydro- 
lase were mixed with an equal volume of 0.03 or 0.1 M HNO:~. Stand- 
ards and unknowns were analyzed in duplicate. 
3. Results 
3.1. Pur(Bcation and physieoehemical properties ~[ Xenopus 
laevis LTA 4 hydrolase 
LTA~ hydrolase was isolated from Xenopus laevis oocytes. 
Typically, the overall purification was about 8000-fold with a 
recovery of 30% (Table 1), resulting in an apparently homo- 
geneous preparation (SDS-PAGE with silver staining). From 
SDS-PAGE, the Mr of the Xenopus laevis LTA~ hydrolase 
was estimated to 69000 and the isoelectric point was found 
to be 6.1, as judged by isoelectric focusing (PhastGel) and 
chromatofocusing (MonoP column). Atomic absorption spec- 
trometry revealed the presence of 0.8 tool zinc per mol en- 
zyme. The amphibian enzyme was not recognized by an anti- 
serum against human LTA4 hydrolase in Western blot 
analysis and attempts to determine the N-terminal amino 
acid sequence did not yield any result, indicating the presence 
of a blocked N-terminus. To make possible an evaluation of 
the structure, the Xenopus laevis enzyme was therefore di- 
gested with Lys-C protease and seven internal peptides, vary- 
ing in length between 5 and 15 amino acid residues, were 
sequenced. Altogether, these peptides contained 62 residues 
Table 1 
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Fig. 1. Reverse-phase HPLC profile of the products formed in incu- 
bations of purified LTA4 hydrolase from Xenopus laevis oocytes 
with LTA4. The reverse-phase HPLC analysis was performed as de- 
scribed in Section 2. PGB1 denotes the internal standard prostaglan- 
din BI. Peaks 1 and 2 elute with two non-enzymatic hydrolysis 
products of LTA4. Peaks 3 and 4 have the same retention times as 
LTB4 and A~-trans-AS-cis-LTB4, respectively. 
and were 60 100% (mean value 74%) identical to human 
LTA~ hydrolase and 17-50% (mean value 32%) identical to 
rat aminopeptidase B. The longest 15 residue peptide (EL- 
LEPSVYEFAETEK)  exhibited 60% identity to the corre- 
sponding segment of human LTA4 hydrolase (residues 225- 
239) but only 27% identity to rat aminopeptidase B (residues 
252 267). 
3.2. Catalytic properties 
The purified Xenopus laevis LTA4 hydrolase (0.2 ~tg) effi- 
ciently converted LTA4 into LTB1 at a pH optimum of 8.5 
(Tris-HC1 or phosphate buffer). The specific epoxide hydro- 
lase activity was 6.7 + 1.6 ~mol/mg/min (mean + S.D., n = 8) as 
compared to only 0.95 + 0.3 ~mol/mg/min (mean + S.D., n -- 4) 
for the human LTA1 h ydrolase (1 ~tg). Multiple exposures (4 
times) to LTA~ (25 ~M, 30 min) led to a partial inactivation 
of the Xenopus [aevis enzyme, suggesting that it was suscep- 
tible to suicide inactivation. 
The Xenopus laevis enzyme also produced a second enzy- 
matic metabolite of LTA~. Thus, reverse-phase HPLC analy- 
sis of enzyme samples incubated with LTA4 revealed four 
peaks (Fig, 1). Peaks 1 and 2 cochromatographed with the 
two non-enzymatic hydrolysis products of LTA4. The third 
peak (3) eluted with synthetic LTB4 whereas the fourth 
peak (4) had the same HPLC retention time and UV spectrum 
(in MeOH) as a recently identified enzymatic product of 
LTA l, viz. 5S, 12R-dihydroxy-8,14-cis-6, lO-trans eicosatetra- 
enoic acid, also termed A6-trans-AS-cis-LTB~ or 5S-12R-di- 
HETE [9]. The formation of A6-trans-AS-cis-LTB~ appeared 
at all stages of purification and always in the ratio 1:10, 
Step Total protein Total activity Specific activity Yield Purification 
(rag) (nmol/mg) (nmol/mg/min) (%) (-fold) 
Dialysis 1650 2018 1.2 100 1 
Q Sepharose 9.5 1900 202 95 168 
Phenyl Sepharose 1.5 1627 1085 80 904 
Hydroxyapatite 0.3 882 3095 44 2580 
MonoP 0.07 486 6480 24 5400 
MonoQ 0.07 l 704 9850 30 8200 
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relative to LTB~. Incubations of the human leukocyte LTA4 
hydrolase with LTA4 generated no other product han LTB4, 
as judged by reverse-phase HPLC. 
When the Xenopus laevis LTA.a hydrolase (0.2 lag) was in- 
cubated in 50 mM Tris-HC1 (pH 7.5), with 100 mM KC1, 
hydrolysis of the synthetic peptidase substrate alanine-4-nitro- 
anilide (1 mM) into alanine and 4-nitroaniline was observed. 
The pH optimum for this peptidase activity (Tris-HCl or 
phosphate buffer) was determined to 7.5. The specific activity 
was calculated to 581 +_ 213 nmol/mg/min (mean + S.D., n = 5). 
Under the same conditions, the human leukocyte nzyme (0.2 
lag) exhibited a specific activity of 209+99 nmol/mg/min 
(mean + S.D., n=4). 
The peptidase activity of the Xenopus laevis LTA4 hydrolase 
towards alanine-4-nitroanilide was dose dependently stimu- 
lated by a number of monovalent anions added as potassium 
and/or sodium salts. The choice of cation did not influence the 
effect of the anion. Among the anions tested, thiocyanate was 
found to be the most effective activator followed by bromide 
and chloride (SCN->>Br >CI -~ I  ~NO:~>>F ). For 
chloride ions, the pattern of stimulation seemed to obey sat- 
uration kinetics and from Eadie-Hofstee plots of the kinetic 
data, an apparent affinity constant (KA) for chloride was cal- 
culated to 80 mM. Bromide or thiocyanate caused a similar 
activation, but concentrations exceeding 200 mM suppressed 
the enzyme activity. A value of K,x for thiocyanate (0 100 
mM) was estimated to 30 mM. Chloride (150-600 mM KC1) 
did not stimulate the epoxide hydrolase activity. 
3.3. Apparent kinetic constants 
Apparent kinetic constants for the two activities were de- 
termined for both the Xenopus laevis and the human LTAa 
hydrolase. Values of K,, and V, .... were calculated from Ea- 
die-Hofstee plots of the kinetic data. 
For the epoxide hydrolase activity, 0.3 lag of the amphibian 
enzyme or 1 lag of the human enzyme were incubated with 
varying amounts of LTA,I (5 90 BM). In a typical experiment 
with the Xenopus laevis enzyme, the K,~ and V~ .... for LTA4 
were calculated to 20 BM and 12.0 gmol/mg/min, respectively 
(mean of duplicates). Corresponding values for the human 
enzyme were 2.7 BM and 1.3 lamol/mg/min (mean of dupli- 
cates), respectively (Table 2). 
For the peptidase activity, 0.25 lag each of Xenopus laevis 
and human LTA~ hydrolase were incubated with varying 
amounts of alanine-4-nitroanilide (0.125-16 mM), The values 
of Kin and V, . . . . .  were determined to 2.4 mM and 1800 nmol/ 
mg/min (mean of triplicates), respectively, for the Xenopus 
laevis enzyme. For the human enzyme the values were 0.7 
mM and 470 nmol/mg/min (mean of triplicates), respectively 
(Table 2). 
4. Discussion 
4.1. General properties of Xenopus laevis LTA4 hydrolase 
In the present study we purified LTA4 hydrolase to appar- 
ent homogeneity from a non-mammalian species, i.e. the 
African claw toad Xenopus laevis (Table 1), making possible 
metal analysis and assay for a peptidase activity. The amphib- 
ian enzyme contained one zinc atom per enzyme molecule and 
displayed a peptide cleaving activity against he synthetic sub- 
strate alanine-4-nitroanilide. H nce, Xenopus laevis LTA,~ hy- 
drolase is a bifunctional zinc metalloenzyme, key properties of 
the mammalian counterparts [4,5]. 
The peptidase activity of the Xenopus laevis LTA1 hydrolase 
was greatly stimulated by monovalent anions. For chloride, 
the physiologically most relevant anion, an apparent affinity 
constant (KA) was calculated to be 80 mM, in good agreement 
with the value of 100 mM previously obtained with the hu- 
man enzyme [6]. The profound and selective ffects of chloride 
suggests that the peptidase activity may be regulated by the 
steady-state l vels or fluxes of this electrolyte. Moreover, fur- 
ther studies are warranted to clarify the function of this pep- 
tide cleaving activity and explain the presence of the enzyme 
in the reproduction organs of Xenopus laevis. 
In contrast o mammalian forms of LTAt hydrolase, the N- 
terminus of the Xenopus laevis enzyme appeared to be 
blocked. Furthermore, the amphibian protein was not de- 
tected in Western blots, using a probe for the human protein. 
To get an estimate of the structural conservation of the Xeno- 
pus laevis enzyme, several internal peptides were isolated and 
sequenced. Thus, seven peptides, encompassing 62amino acid 
residues, were ~ 70% identical to the corresponding segments 
of human LTA4 hydrolase and their sequences clearly distin- 
guished the toad enzyme from aminopeptidase B (,-~30% 
identity), an enzyme which has also been shown to possess 
LTA4 hydrolase activity [8]. 
4.2. The Xenopus laevis LTA4 hydrolase displays a high 
catalytic efficien O" 
The apparent kinetic constants for the epoxide hydrolase 
and peptidase activities differed considerably between the 
Xenopus laevis and human ETA1 hydrolase (Table 2). Thus, 
the value of V, .... for the epoxide hydrolase activity of the 
Xenopus laevis enzyme was approximately 9-fold higher as 
compared to the human enzyme. On the other hand, it dis- 
played a 7-fold higher K,,~ for LTA~ and therefore, the spe- 
cificity constants (k,,~,JKm) for LTAa were almost he same for 
the two species, suggesting that the two active sites are equally 
well adapted to process the substrate LTAt. Of note, due to 
the instability of LTAa we consider the differences in substrate 
turnover (k,~,~t) more significant han those of the Michaelis 
Table 2 
Apparent kinetic constants for the epoxide hydrolase and peptidase activity of LTA4 hydrolase from Xenopus &ev& oocytes and human leuko- 
cytes 
Epoxide hydrolase activity Peptidase activity 
Xenopus laevis Human Xenopus laevis Human 
K,,~ (BM) 20 2.7 2400 700 
V, ..... (gmol/mg/min) 12 1.3 1.8 0.5 
k,.~t (s 1 ) 14 1.5 2.1 0.5 
k~.JK,, (s I M I ) 6.9 × 10:' 5.5 × 10 ~ 860 770 
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Fig. 2, Structure and formation of the enzymatic metabolites of 
LTA4 generated by Xenopus laevis LTA~ hydrolase. 
and, in contrast to [Y378F]LTA4 hydrolase, appears to be 
suicide inactivated by the substrate LTA4. Nevertheless, it is 
tempting to speculate that Tyr-378 is located in a segment of 
LTA4 hydrolase which may determine some of the catalytic 
differences between the human and of the Xenopus laevis en- 
zyme. 
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constant. When comparing the peptidase activities, the values 
of both V~ .... and K~ were again higher (approx. 3.5-fold for 
both parameters) for the Xenopus laevis enzyme. As for the 
epoxide hydrolase activity, the specificity constants (kcatlK, n) 
were almost the same for the two species. 
4.3. The Xenopus laevis LTA~, hydrolase can jbrm a second 
enzymatic metabolite of LTA 4 
In a recent study, we found that organs of Xenopus laevis 
contained an enzyme activity which converted LTA4 into a 
novel, biologically active, product identified as AG-trans-AS-cis - 
LTB4 [9]. The relative formation of A6-trans-A~-cis-LTB4 ver- 
sus LTB4 was always about 1:10. The Xenopus laevis LTA4 
hydrolase that was purified in the present study has the ability 
to convert LTA4 into both A6-trans-AS-cis-LTB4 and LTB~ in 
a ratio of about 1:10 (Fig. 1) and can account for both of the 
enzyme activities observed in the organ extracts (Fig. 2). 
Typically, LTA4 hydrolase becomes suicide inactivated 
and covalently modified by its lipid substrate LTA4 [13]. In 
this process, Tyr-378 is a primary site for covalent binding 
of LTA~ since exchange of this residue for a phenylalanine 
resulted in a recombinant enzyme that was protected from 
suicide inactivation [14]. Interestingly, this mutant, 
[Y378F]LTA4 hydrolase, exhibited an increased turnover of 
LTA4 together with an increased K,,~ and converted LTA~ 
into both LTB4 and A6-trans-AS-cis-LTB4 and thus shares 
several catalytic properties with the Xenopus laevis enzyme. 
However, the latter enzyme is catalytically even more efficient 
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